Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.

Authors: Weng, Mao-Wen; Lee, Hyun-Wook; Choi, Bongkun; Wang, Hsiang-Tsui; Hu, Yu; Mehta, Manju; Desai, Dhimant; Amin, Shantu; Zheng, Yi; Tang, Moon-Shong

Published In Oncotarget, (2017 Mar 14)

Abstract: Aflatoxin B1 (AFB1) contamination in the food chain is a major cause of hepatocellular carcinoma (HCC). More than 60% of AFB1 related HCC carry p53 codon 249 mutations but the causal mechanism remains unclear. We found that 1) AFB1 induces two types of DNA adducts in human hepatocytes, AFB1-8,9-epoxide-deoxyguanosine (AFB1-E-dG) induced by AFB1-E and cyclic α-methyl-γ-hydroxy-1,N2-propano-dG (meth-OH-PdG) induced by lipid peroxidation generated acetaldehyde (Acet) and crotonaldehyde (Cro); 2) the level of meth-OH-PdG is >30 fold higher than the level of AFB1-E-dG; 3) AFB1, Acet, and Cro, but not AFB1-E, preferentially induce DNA damage at codon 249; 4) methylation at -CpG- sites enhances meth-OH-PdG formation at codon 249; and 5) repair of meth-OH-PdG at codon 249 is poor. AFB1, Acet, and Cro can also inhibit DNA repair and enhance hepatocyte mutational sensitivity. We propose that AFB1-induced lipid peroxidation generated aldehydes contribute greatly to hepatocarcinogenesis and that sequence specificity of meth-OH-PdG formation and repair shape the codon 249 mutational hotspot.

PubMed ID: 28212554 Exiting the NIEHS site

MeSH Terms: Aflatoxin B1/toxicity*; Aldehydes/metabolism*; Carcinoma, Hepatocellular/chemically induced; Carcinoma, Hepatocellular/genetics; Carcinoma, Hepatocellular/metabolism; Carcinoma, Hepatocellular/pathology; Codon/drug effects; DNA Adducts/biosynthesis*; DNA Repair/drug effects*; Genes, p53/drug effects*; Hep G2 Cells; Humans; Lipid Peroxidation/drug effects; Liver Neoplasms/chemically induced*; Liver Neoplasms/genetics; Liver Neoplasms/metabolism; Liver Neoplasms/pathology; Mutation

to Top